Investigator: Neal Kleiman, MD

Study Coordinator: Patricia Brinegar

Status: Enrolling Number: NCT02202434

Phone: 713.441.3506

Protocol Number: Pro00011356


The objective of this study is to evaluate the safety and effectiveness of the Lotus™ Valve System for transcatheter aortic valve replacement (TAVR) in symptomatic subjects with calcific, severe native aortic stenosis who are considered at extreme or high risk for surgical valve replacement.
More to Explore